Immunomodulation of IFN-ã, IL-4, and IL-10 Cytokines by Polyherbal Formulation in Cyclophosphamide-Induced Immunosuppression among Wistar Rats

K. M. Hamid, N. Abubakar, M. Yeldu, M. Abdullahi, A. Usman, S. Isah, M. Aliyu
{"title":"Immunomodulation of IFN-ã, IL-4, and IL-10 Cytokines by Polyherbal Formulation in Cyclophosphamide-Induced Immunosuppression among Wistar Rats","authors":"K. M. Hamid, N. Abubakar, M. Yeldu, M. Abdullahi, A. Usman, S. Isah, M. Aliyu","doi":"10.4314/sokjmls.v7i2.1","DOIUrl":null,"url":null,"abstract":"This study evaluated the immunomodulatory potential of aqueous extract of polyherbal formulation (PHF) in cyclophosphamide (CP)- induced immunosuppression in Wistar albino rats. The rats were randomly divided into six (6) groups of four (4) rats each. The normal control group received 10 ml/kg b.w of normal saline for 28 days orally. The Positive control group received 50mg/kg b.w of Levamisole Hydrochloride for 28 days orally.  Cyclophosphamide (CP) control group had 10 mg/ kg b.w of CP for three days subcutaneously.  While the Treatment control group received 1500 mg/ kg b.w of PHF orally for 28 days. Treatment 1 group received 10 mg/ kg b.w of CP for three days subcutaneously, followed by oral administration of 1500 mg/ kg b.w of PHF for 28 days.  Lastly, Treatment 2 group received 1500 mg/ kg b.w of PHF for 28 days orally, followed by subcutaneous administration of 10 mg/ kg b.w of CP for three days. On the first day prior to any intervention, 1 ml of the blood sample was collected from each rat which serve as a pre-treatment sample. At the end of the experiment (after 28 days), a blood sample was collected from each rat which serve as a post-treatment sample. The serum concentration of IFN-ã, IL-4, and IL-10 were determined using the ELISA technique. For pre-treatment samples, there was no statistically significant difference in the mean serum concentration of the cytokines across the groups (p >0.05). For post-treatment samples, there was a statistically significant difference in the mean serum concentration of IFN-ã (p < 0.0001) and IL-4 (p<0.001) across the groups. There was a significant difference when normal controls were compared with other groups in IFN-ã and IL-4 (p <0.05). No significant difference was observed in IL-10. The formulation seems to neutralise the immunosuppressive condition and induce immunostimulatory activity on the immune cells responsible for the secretion of IFN-ã and IL-4.","PeriodicalId":92723,"journal":{"name":"Sokoto journal of medical laboratory science","volume":"204 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sokoto journal of medical laboratory science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/sokjmls.v7i2.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This study evaluated the immunomodulatory potential of aqueous extract of polyherbal formulation (PHF) in cyclophosphamide (CP)- induced immunosuppression in Wistar albino rats. The rats were randomly divided into six (6) groups of four (4) rats each. The normal control group received 10 ml/kg b.w of normal saline for 28 days orally. The Positive control group received 50mg/kg b.w of Levamisole Hydrochloride for 28 days orally.  Cyclophosphamide (CP) control group had 10 mg/ kg b.w of CP for three days subcutaneously.  While the Treatment control group received 1500 mg/ kg b.w of PHF orally for 28 days. Treatment 1 group received 10 mg/ kg b.w of CP for three days subcutaneously, followed by oral administration of 1500 mg/ kg b.w of PHF for 28 days.  Lastly, Treatment 2 group received 1500 mg/ kg b.w of PHF for 28 days orally, followed by subcutaneous administration of 10 mg/ kg b.w of CP for three days. On the first day prior to any intervention, 1 ml of the blood sample was collected from each rat which serve as a pre-treatment sample. At the end of the experiment (after 28 days), a blood sample was collected from each rat which serve as a post-treatment sample. The serum concentration of IFN-ã, IL-4, and IL-10 were determined using the ELISA technique. For pre-treatment samples, there was no statistically significant difference in the mean serum concentration of the cytokines across the groups (p >0.05). For post-treatment samples, there was a statistically significant difference in the mean serum concentration of IFN-ã (p < 0.0001) and IL-4 (p<0.001) across the groups. There was a significant difference when normal controls were compared with other groups in IFN-ã and IL-4 (p <0.05). No significant difference was observed in IL-10. The formulation seems to neutralise the immunosuppressive condition and induce immunostimulatory activity on the immune cells responsible for the secretion of IFN-ã and IL-4.
复方对环磷酰胺诱导的Wistar大鼠免疫抑制中IFN-ã、IL-4和IL-10细胞因子的免疫调节作用
本研究评价了复方水提物(PHF)对环磷酰胺(CP)诱导的Wistar白化大鼠免疫抑制的免疫调节作用。将大鼠随机分为6组,每组4只大鼠。正常对照组给予生理盐水10 ml/kg b.w,连续口服28 d。阳性对照组患者给予盐酸左旋咪唑50mg/kg b.w口服28 d。环磷酰胺(CP)对照组皮下注射CP 10 mg/ kg b.w,连续3 d。治疗对照组给予1500 mg/ kg b.w的PHF,连续口服28 d。治疗1组皮下给予CP 10 mg/ kg b.w,连续3 d,随后口服PHF 1500 mg/ kg b.w,连续28 d。最后,治疗2组给予1500 mg/ kg b.w的PHF,连续28 d,随后皮下给予10 mg/ kg b.w的CP,连续3 d。在任何干预前的第一天,从每只大鼠身上采集1 ml血液样本作为预处理样本。在实验结束时(28天后),从每只大鼠身上采集血液样本作为治疗后样本。ELISA法测定血清中IFN-ã、IL-4、IL-10的浓度。预处理样品各组间血清细胞因子平均浓度比较,差异无统计学意义(p >0.05)。对于治疗后样本,两组间IFN-ã平均血清浓度(p< 0.0001)和IL-4平均血清浓度(p<0.001)差异有统计学意义。正常对照组与其他各组IFN-ã、IL-4比较差异有统计学意义(p <0.05)。IL-10无显著性差异。该配方似乎可以中和免疫抑制状况,并诱导免疫细胞分泌IFN-ã和IL-4的免疫刺激活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信